Morgan Stanley (MS) Posts Record Q2 2026 Earnings on Surging Trading and Banking Revenue
Key Takeaways
- Record revenue and earnings: Morgan Stanley posted net revenues of $21.3 billion and diluted earnings per share (EPS) of $3.46 for the second quarter of 2026, both all-time highs that handily exceeded analyst consensus estimates.
- Equities trading surged 69%: Equity sales and trading revenue reached a record $6.3 billion, driven by heightened client activity amid global market volatility, geopolitical tensions, and shifting interest rate expectations.
- Investment banking rebounded powerfully: Investment banking revenue jumped 58% year over year to $2.44 billion, fueled by a boom in mergers and acquisitions (M&A) and blockbuster initial public offerings (IPOs), including the SpaceX debut.
- Wealth Management hit a milestone: The division attracted a record $148 billion in net new assets, pushing combined client assets across Wealth and Investment Management past the $10 trillion mark for the first time.
- Profitability metrics strengthened: Return on tangible common equity (ROTCE) — a key measure of a bank's profitability from its core operations — reached 26.6%, while the efficiency ratio improved to 65% from 71% a year earlier.
- Share buyback fell short of some expectations: The firm repurchased $1.5 billion in shares, below one analyst estimate of $1.8 billion, which contributed to a muted initial stock reaction despite the blockbuster results.
Why These Results Matter in Today’s Market
Morgan Stanley’s second-quarter 2026 results arrived at a pivotal moment for global financial markets. The first half of 2026 saw M&A activity surge to $2.8 trillion — the strongest first-half total since LSEG began tracking records in 1980 — while equity markets remained buoyant despite ongoing geopolitical tensions, persistent inflation concerns, and a more hawkish Federal Reserve stance. For Morgan Stanley, this environment created a tailwind across all three of its major business lines: Institutional Securities, Wealth Management, and Investment Management. The report matters not only because it reflects the health of Wall Street’s core profit engines — trading and dealmaking — but also because it showcases how Morgan Stanley’s diversified model, combining high-octane capital markets with steady fee-based wealth management income, performs under real-world stress and opportunity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Breaking Down the Reported Numbers
Morgan Stanley reported net revenues of $21.3 billion for the second quarter ended June 30, 2026, a 27% increase from $16.8 billion in the same period a year ago. This result crushed the consensus analyst estimate of approximately $19.6 billion. Net income applicable to Morgan Stanley came in at $5.58 billion, or $3.46 per diluted share, up sharply from $3.54 billion, or $2.13 per share, a year earlier. Analysts had forecast EPS of roughly $2.93 to $2.94, meaning the bank delivered an earnings beat of approximately 18%.
The Institutional Securities division was the standout performer, generating record quarterly revenue of $11 billion — a 44.7% year-over-year jump. Equities trading revenue alone soared 69% to $6.3 billion, as market volatility tied to the U.S.-Iran conflict, oil price swings, and shifting Federal Reserve policy expectations drove heavy client hedging and portfolio repositioning. Fixed income net revenue rose 13%. Investment banking revenue reached $2.44 billion, up 58%, with advisory fees climbing to $798 million and both equity and fixed income underwriting significantly exceeding forecasts. Morgan Stanley served as lead underwriter on SpaceX’s record IPO, advised Fertitta Entertainment on its $17.6 billion acquisition of Caesars Entertainment, and acted as joint book-running manager on Alphabet’s equity capital raise. From what I see, the equities trading surge stands out as a direct reflection of client demand in uncertain times.
Wealth Management generated $8.9 billion in revenue, up from $7.8 billion a year ago. Net new assets reached a record $148 billion, far outpacing analyst expectations of around $55 billion to $67 billion. Over half of those inflows came through IPO-related activity in the workplace services channel. Total client assets in the wealth division rose 25% to $8.08 trillion, and combined with Investment Management, total client assets crossed the $10 trillion milestone. The firm’s Common Equity Tier 1 (CET1) ratio — a measure of a bank’s core capital strength — held steady at 14.8%. Return on equity (ROE) reached 20.7%, and ROTCE hit 26.6%, both comfortably above consensus estimates.
How the Market Reacted
Despite the overwhelmingly strong headline numbers, Morgan Stanley shares initially dipped approximately 1.2% in pre-market trading on July 15 before recovering to close roughly 1% higher at around $229.94. The mixed intraday action reflected a classic “buy the rumor, sell the fact” dynamic: the stock had already rallied roughly 28.5% year-to-date heading into the report, and peer banks including Goldman Sachs and JPMorgan Chase had already posted similarly robust results the day prior, reducing the element of surprise. One specific point of investor scrutiny was the firm’s $1.5 billion in share repurchases during the quarter, which fell short of KBW analyst Chris McGratty’s $1.8 billion estimate. The board did raise the quarterly dividend to $1.15 per share and reauthorized a $20 billion repurchase program, but those moves were largely anticipated. The broader takeaway, however, was that execution was strong across the board, and analyst commentary remained broadly constructive following the call.
What to Watch in the Second Half
Looking ahead, Morgan Stanley enters the second half of 2026 with considerable momentum, but several factors will determine whether the record-setting pace can be sustained.
First, the investment banking pipeline remains robust. The M&A environment continues to benefit from improving CEO confidence, a relatively accommodative regulatory backdrop, and strong equity market valuations that encourage dealmaking. The IPO calendar, headlined by the SpaceX debut, suggests that equity underwriting fees could remain elevated, though activity levels are inherently unpredictable and sensitive to sudden shifts in market sentiment or geopolitical stability.
Second, trading revenues — which reached an all-time high this quarter — are by nature volatile. Continued geopolitical friction, persistent inflation readings, and any Federal Reserve policy surprises could sustain elevated trading volumes, but a sudden calm in markets would present a tough comparison for the Institutional Securities division in the quarters ahead. I’m watching this closely as a potential driver of near-term results.
Third, the Wealth Management business is increasingly becoming the firm’s anchor. With $148 billion in net new assets this quarter and total client assets now above $10 trillion, the division provides a growing base of recurring fee income that can buffer against capital markets cycles. Investors should monitor net new asset trends, loan growth, and deposit costs in this segment for signs of sustained momentum or emerging pressure.
Finally, capital allocation will remain under the microscope. The $20 billion buyback authorization provides ample runway, but the pace of actual repurchases relative to market expectations — and whether the firm deploys capital toward acquisitions, as CEO Ted Pick has indicated is possible under strict criteria — will be a key narrative. Cost discipline, reflected in the improved 65% efficiency ratio, will also be watched closely as the firm balances investment in growth with profitability targets.
Refining Research with AI Tools
In my regular analysis of earnings seasons, I turn to Tickeron’s AI Screener to quickly filter opportunities and compare names like Morgan Stanley against peers using technical indicators and AI signals. It helps surface ideas that align with broader sector trends without replacing traditional due diligence.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MS sees its Stochastic Oscillator recovers from oversold territory
On October 06, 2026, the Stochastic Oscillator for MS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In 45 of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MS's RSI Oscillator exited the oversold zone, 14 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In 40 of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 56%.
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 25 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
MS moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for MS entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 13 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.854) is normal, around the industry mean (4.351). P/E Ratio (15.641) is within average values for comparable stocks, (30.023). Projected Growth (PEG Ratio) (1.702) is also within normal values, averaging (0.809). Dividend Yield (0.021) settles around the average of (0.016) among similar stocks. P/S Ratio (4.380) is also within normal values, averaging (16.763).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers
Advertisement